Bernaola Aponte Guillermo, Bada Mancilla Carlos Alfonso, Carreazo Nilton Yhuri, Rojas Galarza Raúl Alberto
Suárez Angamos Hospital, Angamos Este Avenue 261, Miraflores, Lima, Peru, 18.
Cochrane Database Syst Rev. 2013 Aug 20;2013(8):CD007401. doi: 10.1002/14651858.CD007401.pub3.
Persistent diarrhoea (diarrhoea lasting more than 14 days) accounts for one third of all diarrhoea related deaths in developing countries in some studies. Probiotics may help treatment.
To evaluate probiotics for treating persistent diarrhoea in children.
We searched the Cochrane Infectious Diseases Group Specialized Register, CENTRAL, MEDLINE, EMBASE, and LILACS. We also contacted authors of included trials and organizations working in the field, and checked reference lists. The date of the most recent search was 13 December 2012 SELECTION CRITERIA: Randomized controlled trials comparing a specified probiotic agent with placebo or no probiotic in children with persistent diarrhoea.
Two review authors assessed the eligibility, risk of bias, extracted and analysed data. Differences were resolved by discussion. Statistical analysis were performed using the fixed-effect model and the results were expressed as mean difference (MD) for continuous outcomes with 95% confidence intervals (CI).
Four trials were included, with a total number of 464 participants; one trial had a low risk of bias. Meta-analysis showed that probiotics reduced the duration of persistent diarrhoea (mean difference 4.02 days, 95% CI 4.61 to 3.43 days, n = 324, two trials). Stool frequency was reduced with probiotics in two trials. One trial reported a shorter hospital stay, which was significant, but numbers were small. No adverse events were reported.
AUTHORS' CONCLUSIONS: There is limited evidence suggesting probiotics may be effective in treating persistent diarrhoea in children.
在一些研究中,持续性腹泻(腹泻持续超过14天)占发展中国家所有腹泻相关死亡病例的三分之一。益生菌可能有助于治疗。
评估益生菌治疗儿童持续性腹泻的效果。
我们检索了Cochrane传染病组专业注册库、Cochrane系统评价数据库、医学期刊数据库、荷兰医学文摘数据库和拉丁美洲及加勒比地区卫生科学数据库。我们还联系了纳入试验的作者以及该领域的相关组织,并查阅了参考文献列表。最近一次检索日期为2012年12月13日。
比较特定益生菌制剂与安慰剂或无益生菌对持续性腹泻儿童疗效的随机对照试验。
两名综述作者评估了研究的纳入资格、偏倚风险,提取并分析了数据。通过讨论解决分歧。采用固定效应模型进行统计分析,结果以连续变量结局的平均差(MD)及其95%置信区间(CI)表示。
纳入四项试验,共464名参与者;一项试验偏倚风险较低。荟萃分析表明,益生菌可缩短持续性腹泻的持续时间(平均差4.02天,95%CI 4.61至3.43天,n = 324,两项试验)。两项试验中益生菌使排便次数减少。一项试验报告住院时间缩短,差异有统计学意义,但样本量较小。未报告不良事件。
有有限的证据表明益生菌可能有效治疗儿童持续性腹泻。